Floatz logo

Allogeneic Donor Derived B-Lymphocytes

Aplastic Anemia

University of Erlangen-Nürnberg Medical SchoolCell therapyPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

16 Active assets in the Aplastic Anemia cohort.

Asset / SponsorPhaseRating
Fludarabine
Thomas Jefferson University
Phase 2BBB
Cyclophosphamide
Thomas Jefferson University
Phase 3BBB
TACROLIMUS
Thomas Jefferson University
Phase 2BB
FILGRASTIM
Thomas Jefferson University
Phase 2BB
Anti-Thymoglobulin, Rabbit
M.D. Anderson Cancer Center
Phase 3BB

View all 36 →

Same molecule, other indications

Allogeneic Donor Derived B-Lymphocytes is also rated in:

non-Hodgkin lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
Hodgkins lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
chronic myeloid leukemiaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →